It is meaningful to take into account the potential therapeutic strategies of reducing breast cancer angiogenesis by targeting FBXW7 and its downstream proteins in light of the critical function that FBXW7 plays in modulating angiogenesis. This evidence concerns the gene FBXW7 and breast cancer.